TY - JOUR
T1 - Monocytes, neutrophils, and platelets cooperate to initiate and propagate venous thrombosis in mice in vivo
AU - von Bruehl, Marie-Luise
AU - Stark, Konstantin
AU - Steinhart, Alexander
AU - Chandraratne, Sue
AU - Konrad, Ildiko
AU - Lorenz, Michael
AU - Khandoga, Alexander
AU - Tirniceriu, Anca
AU - Coletti, Raffaele
AU - Koellnberger, Maria
AU - Byrne, Robert A.
AU - Laitinen, Iina
AU - Walch, Axel
AU - Brill, Alexander
AU - Pfeiler, Susanne
AU - Manukyan, Davit
AU - Braun, Siegmund
AU - Lange, Philipp
AU - Riegger, Julia
AU - Ware, Jerry
AU - Eckart, Annekathrin
AU - Haidari, Selgai
AU - Rudelius, Martina
AU - Schulz, Christian
AU - Echtler, Katrin
AU - Brinkmann, Volker
AU - Schwaiger, Markus
AU - Preissner, Klaus T.
AU - Wagner, Denisa D.
AU - Mackman, Nigel
AU - Engelmann, Bernd
AU - Massberg, Steffen
PY - 2012/4/9
Y1 - 2012/4/9
N2 - Deep vein thrombosis (DVT) is a major cause of cardiovascular death. The sequence of events that promote DVT remains obscure, largely as a result of the lack of an appropriate rodent model. We describe a novel mouse model of DVT which reproduces a frequent trigger and resembles the time course, histological features, and clinical presentation of DVT in humans. We demonstrate by intravital two-photon and epifluorescence microscopy that blood monocytes and neutrophils crawling along and adhering to the venous endothelium provide the initiating stimulus for DVT development. Using conditional mutants and bone marrow chimeras, we show that intravascular activation of the extrinsic pathway of coagulation via tissue factor (TF) derived from myeloid leukocytes causes the extensive intraluminal fibrin formation characteristic of DVT. We demonstrate that thrombus-resident neutrophils are indispensable for subsequent DVT propagation by binding factor XII (FXII) and by supporting its activation through the release of neutrophil extracellular traps (NETs). Correspondingly, neutropenia, genetic ablation of FXII, or disintegration of NETs each confers protection against DVT amplification. Platelets associate with innate immune cells via glycoprotein Ib alpha and contribute to DVT progression by promoting leukocyte recruitment and stimulating neutrophil-dependent coagulation. Hence, we identified a cross talk between monocytes, neutrophils, and platelets responsible for the initiation and amplification of DVT and for inducing its unique clinical features.
AB - Deep vein thrombosis (DVT) is a major cause of cardiovascular death. The sequence of events that promote DVT remains obscure, largely as a result of the lack of an appropriate rodent model. We describe a novel mouse model of DVT which reproduces a frequent trigger and resembles the time course, histological features, and clinical presentation of DVT in humans. We demonstrate by intravital two-photon and epifluorescence microscopy that blood monocytes and neutrophils crawling along and adhering to the venous endothelium provide the initiating stimulus for DVT development. Using conditional mutants and bone marrow chimeras, we show that intravascular activation of the extrinsic pathway of coagulation via tissue factor (TF) derived from myeloid leukocytes causes the extensive intraluminal fibrin formation characteristic of DVT. We demonstrate that thrombus-resident neutrophils are indispensable for subsequent DVT propagation by binding factor XII (FXII) and by supporting its activation through the release of neutrophil extracellular traps (NETs). Correspondingly, neutropenia, genetic ablation of FXII, or disintegration of NETs each confers protection against DVT amplification. Platelets associate with innate immune cells via glycoprotein Ib alpha and contribute to DVT progression by promoting leukocyte recruitment and stimulating neutrophil-dependent coagulation. Hence, we identified a cross talk between monocytes, neutrophils, and platelets responsible for the initiation and amplification of DVT and for inducing its unique clinical features.
U2 - 10.1084/jem.20112322
DO - 10.1084/jem.20112322
M3 - Article
SN - 0022-1007
VL - 209
SP - 819
EP - 835
JO - Journal of Experimental Medicine
JF - Journal of Experimental Medicine
IS - 4
ER -